Sep 2026
SMARCA4-deficient Anaplastic Thyroid Carcinoma: A Hitherto Unreported Case.
Khushi Naik, Neha Mittal, Nupur Karnik et al.
· Virchows Archiv · 0 citations
We have 3 of 850 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Sep 2026
MRI radiomics-based predictive modeling for risk stratification and prognostication in oral tongue carcinoma
By identifying low-risk patients within the NCCN high-risk group and high-risk patients within the NCCN low + intermediate-risk group for recurrence, these models may support treatment de-escalation and escalation, respectively, pending prospective multicenter validation.
N. Chakrabarty, S. Rane, U. Sherkhane et al.
· Frontiers in Oncology · 1 citation
Review
Aug 2026
KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms
KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.
A. Kapoor, Bipinesh Sansar, Anuj Gupta et al.
· Medical Oncology · 0 citations